PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , provider of advanced wound care products, announced plans to release its third quarter 2008 results before market on Monday, November 17, 2008. The Company will hold a conference call that same day to discuss the results at 11:00 am EST. Interested parties should call 800 299 0433 (domestic) or 617 801 9712 (international), with passcode 96313249 to access the call. You may also access this call via the Internet at:
http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=1998826
For those who are unavailable to listen to the live broadcast, a replay will be available through December 17, 2008 and can be accessed by dialing 888 286 8010 (domestic) or 617 801 6888 (international) and using passcode 18191744.
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.
CONTACT: Edward J. Quilty, Chairman and CEO of Derma Sciences, Inc.,
+1-609-514-4744, equilty@dermasciences.com; or US Investors, Rudy Barrio,
r.barrio@allencaron.com, or media, Brian Kennedy, brian@allencaron.com,
both of Allen & Caron Inc, +1-212-691-8087, for Derma Sciences, Inc.
